Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This filing is a Current Report on Form 8-K dated May 2, 2019, regarding the results of the Annual Meeting of Stockholders held on that date. The company is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol ACHC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: Class II directors William F. Grieco and Reeve B. Waud were elected to serve until the 2022 annual meeting.
- William F. Grieco: 71,921,269 votes For; 2,778,320 Against.
- Reeve B. Waud: 60,643,024 votes For; 14,061,867 Against.
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of Named Executive Officers on a non-binding advisory basis with 67,482,950 votes For and 6,320,160 Against.
- Frequency of Say-on-Pay Vote: Stockholders selected a one-year frequency for future advisory votes on executive compensation (73,339,493 votes for 1 Year). The Board has determined to hold these votes annually.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019, with 77,705,612 votes For.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that the Board will hold annual advisory votes on executive compensation based on the May 2, 2019, stockholder decision.
- Verification of the specific terms of the engagement with Ernst & Young LLP for the 2019 fiscal year.
- Review of the definitive proxy statement filed on March 21, 2019, for details on the executive compensation package that was approved.